Onesource Specialty Pharma Limited — Others, 31-07-2025: Shareholders meeting

OneSource Specialty Pharma shareholders have approved all resolutions via postal ballot. This includes the appointment of Mr. Colin Michael Bond as an Independent Director for a five-year term, passing with an overwhelming 99.96% of votes in favour from 7.32 Cr polled votes. The revision in remuneration for Mr. Neeraj Sharma, the Managing Director, was also approved, securing 82.93% of votes in favour from 7.31 Cr polled votes. These key approvals strengthen the company's board and management structure, supporting operational stability.